400P Phase I study of fianlimab, a human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced melanoma (mel)

Subjects

Subjects :

Oncology
Hematology

Details

ISSN :

09237534

Volume :

33

Database :

OpenAIRE

Journal :

Annals of Oncology

Accession number :

edsair.doi...........b9d28ff07b2b53cf514ed6391a504807